CIK 0001022899 · Non-accelerated filer<br>Smaller reporting company
Protagenic Therapeutics, Inc.new
Sign in to watch- Ticker
- PTIX
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Mar 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 061390025
- Phone
- (212) 994-8200
- Business address
- 149 FIFTH AVENUE, SUITE 500, NEW YORK, NY, 10010
- Former names
- Atrinsic, Inc., NEW MOTION, INC., MPLC, Inc., MILLBROOK PRESS INC
- UPLOAD Other SEC-generated Letter
- 8-K Event Delisting notice
- S-3 Offering Registration Statement
- 8-K Event Other events
- SC 13D/A Stake Beneficial Ownership Report
- D Other Notice of Sales of Unregistered Securities
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change
- 4 Insider Changes in Ownership
- SC 13G/A Stake Amended Statement of Ownership
- 8-K Event Material agreement · New debt or obligation · Unregistered share sale
- 10-Q Report Quarterly Report
- 10-K/A Report 10-K/A
- 8-K Event Executive or director change
- 8-K Event Delisting notice
- 10-K Report Annual Report
- NT 10-K Other NT 10-K
- 8-K Event Results of operations
- 8-K Event Executive or director change
- SC 13G/A Stake Amended Statement of Ownership
Page 20 of 36 · 707 filings